ARCHIVES

Guidelines Working Group Agrees On 4750,00 As Base; Steckel Says AACI May Object To “Freeze” On Core

This article is from The Cancer Letter archive.

Vol. 06 No. 46 | November 21, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis

March 13, 1987

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

Fountain Displays Some Statesmanship

July 8, 1977

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Avon 1995 Grant Application Available

December 2, 1994

Moffitt, Ohio State Form Network, Invite Major Cancer Centers to Join

May 30, 2014